欢迎来到康何欣生物!
首页> 产品 > 一抗
CPA1970
  • Western blot analysis of Focal Adhesion Kinase (Phospho-Y576) expression in HEK293T Forskolin-treated (A), NIH3T3 Forskolin-treated (B), H9C2 Forskolin-treated (C) whole cell lysates. (Predicted band size: 119; 99; 63; 48; 120; 39; 114 kD; Observed band size: 125 kD)
产品名称:Anti-Focal Adhesion Kinase (Phospho-Y576) Antibody
货号:CPA1970
来源:Rabbit
反应物种:H, M, R, C
实验应用:WB
*反应物种注解:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
*实验应用注解:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
规格
价格(元)
200 μl
4200
100 μl
2600
30 μl
1300
50 μl
1700
Ship in 3 days
产品描述:Rabbit polyclonal antibody to Focal Adhesion Kinase (Phospho-Y576)
免疫原:KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y576 of human Focal Adhesion Kinase protein. The exact sequence is proprietary.
纯化方式:The antibody was purified by immunogen affinity chromatography.
克隆类型:Polyclonal
产品形式:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
稀释比:WB (1/500 - 1/1000)
基因名称:PTK2
相关名称:FAK; FAK1; Focal adhesion kinase 1; FADK 1; Focal adhesion kinase-related nonkinase; FRNK; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Protein-tyrosine kinase 2; p125FAK; pp125FAK
基因编号(人): 5747;
基因编号(小鼠): 14083;
基因编号(大鼠): 25614;
蛋白编号(人): Q05397;
蛋白编号(小鼠): P34152;
蛋白编号(大鼠): O35346;
储存效期:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
  • Western blot analysis of Focal Adhesion Kinase (Phospho-Y576) expression in HEK293T Forskolin-treated (A), NIH3T3 Forskolin-treated (B), H9C2 Forskolin-treated (C) whole cell lysates. (Predicted band size: 119; 99; 63; 48; 120; 39; 114 kD; Observed band size: 125 kD)
Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing
Journal Clin Cancer Res
IF 11.5
Application IHC-P
Reactivity Human
PMID 21810917
苏州康何欣生物科技有限公司
Copyright © 2025 苏州康何欣生物科技有限公司. All Rights Reserved 苏ICP备2024141444号